The Atherosclerosis Drugs Market continues to play a vital role in cardiovascular care, but it faces significant barriers that hinder progress. From regulatory complexities and affordability issues to clinical trial challenges and limited awareness, these barriers slow down innovation and restrict access to effective treatments for patients worldwide. Regulatory Barriers Drug approval processes...